Krensavage Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-650,089
| Closed | -$28M | – | 14 |
|
|
2024
Q2 | $28M | Buy |
650,089
+2,221
| +0.3% | +$94.3K | 12.83% | 4 |
|
|
2024
Q1 | $27.4M | Buy |
647,868
+1,415
| +0.2% | +$59.6K | 12.16% | 4 |
|
|
2023
Q4 | $27M | Buy |
646,453
+5,718
| +0.9% | +$211K | 9.58% | 6 |
|
|
2023
Q3 | $24.2M | Sell |
640,735
-2,345
| -0.4% | -$88K | 8.9% | 7 |
|
|
2023
Q2 | $24.4M | Buy |
643,080
+1,170
| +0.2% | +$36.7K | 7.73% | 7 |
|
|
2023
Q1 | $15.6M | Sell |
641,910
-2,754
| -0.4% | -$80.3K | 4.74% | 9 |
|
|
2022
Q4 | $18.7M | Buy |
644,664
+63,871
| +11% | +$1.89M | 5.78% | 9 |
|
|
2022
Q3 | $17.4M | Buy |
580,793
+269
| +0% | +$9.28K | 5.54% | 9 |
|
|
2022
Q2 | $21M | Buy |
580,524
+14,573
| +3% | +$556K | 6.94% | 9 |
|
|
2022
Q1 | $24.5M | Buy |
565,951
+26,984
| +5% | +$1.26M | 8.44% | 7 |
|
|
2021
Q4 | $27M | Sell |
538,967
-6,616
| -1% | -$371K | 9.37% | 7 |
|
|
2021
Q3 | $34.7M | Buy |
545,583
+1,878
| +0.3% | +$130K | 10.89% | 5 |
|
|
2021
Q2 | $39.1M | Sell |
543,705
-3,934
| -0.7% | -$289K | 13.28% | 5 |
|
|
2021
Q1 | $40.4M | Sell |
547,639
-6,007
| -1% | -$456K | 13.98% | 3 |
|
|
2020
Q4 | $40.6M | Buy |
553,646
+16,268
| +3% | +$1.05M | 11.87% | 3 |
|
|
2020
Q3 | $29.5M | Buy |
537,378
+15,871
| +3% | +$988K | 9.38% | 6 |
|
|
2020
Q2 | $34.7M | Buy |
521,507
+34,232
| +7% | +$2.3M | 9.43% | 6 |
|
|
2020
Q1 | $29.8M | Buy |
487,275
+147,456
| +43% | +$10.9M | 9.59% | 6 |
|
|
2019
Q4 | $29.9M | Buy |
+339,819
| New | +$28.7M | 10.2% | 7 |
|
Other funds holding TARO
Krensavage Asset Management's TARO Position: Q3 2024 in Review
Krensavage Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2024, closing a stake of 650,089 shares — an estimated $28M sold.
Krensavage Asset Management first reported a position in TARO in Q4 2019 and held it in 19 quarters. The position peaked at $40.6M in Q4 2020. 6 funds tracked by Wall St. Rank hold TARO as of Q3 2024.
- Krensavage Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2024 after selling out during the quarter.
- Krensavage Asset Management sold 650,089 Taro Pharmaceutical Industries Ltd. shares in Q3 2024, an estimated $28M.
- Krensavage Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2019 and held it in 19 quarters.
- Krensavage Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $40.6M in Q4 2020.
- 6 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2024.
Based on Krensavage Asset Management's 13F filing for Q3 2024, filed 15 Nov 2024.